1016 related articles for article (PubMed ID: 11422104)
21. Growth hormone replacement therapy improves body composition and increases bone metabolism in elderly patients with pituitary disease.
Fernholm R; Bramnert M; Hägg E; Hilding A; Baylink DJ; Mohan S; Thorén M
J Clin Endocrinol Metab; 2000 Nov; 85(11):4104-12. PubMed ID: 11095440
[TBL] [Abstract][Full Text] [Related]
22. Comparison of continuation or cessation of growth hormone (GH) therapy on body composition and metabolic status in adolescents with severe GH deficiency at completion of linear growth.
Carroll PV; Drake WM; Maher KT; Metcalfe K; Shaw NJ; Dunger DB; Cheetham TD; Camacho-Hübner C; Savage MO; Monson JP
J Clin Endocrinol Metab; 2004 Aug; 89(8):3890-5. PubMed ID: 15292323
[TBL] [Abstract][Full Text] [Related]
23. Interdependence of lean body mass and total body water, but not quality of life measures, during low dose GH replacement in GH-deficient adults.
Mukherjee A; Adams JE; Smethurst L; Shalet SM
Eur J Endocrinol; 2005 Nov; 153(5):661-8. PubMed ID: 16260424
[TBL] [Abstract][Full Text] [Related]
24. A therapeutic trial of growth hormone in hypopituitary adults and its influence upon continued prescription by general practitioners.
Davies JS; Obuobie K; Smith J; Rees DA; Furlong A; Davies N; Evans LM; Scanlon MF
Clin Endocrinol (Oxf); 2000 Mar; 52(3):295-303. PubMed ID: 10718827
[TBL] [Abstract][Full Text] [Related]
25. Low-dose GH replacement improves the adverse lipid profile associated with the adult GH deficiency syndrome.
Murray RD; Wieringa GE; Lissett CA; Darzy KH; Smethurst LE; Shalet SM
Clin Endocrinol (Oxf); 2002 Apr; 56(4):525-32. PubMed ID: 11966746
[TBL] [Abstract][Full Text] [Related]
26. [Efficacy and safety of recombinant human growth hormone solution in children with growth hormone deficiency in China: a multicenter trial].
Hou L; Luo XP; Du ML; Ma HM; Gong CX; Li YC; Shen SX; Zhao ZH; Liang L; Dong GP; Yan CY; Du HW
Zhonghua Er Ke Za Zhi; 2009 Jan; 47(1):48-52. PubMed ID: 19573383
[TBL] [Abstract][Full Text] [Related]
27. Growth hormone versus placebo treatment for one year in growth hormone deficient adults: increase in exercise capacity and normalization of body composition.
Jørgensen JO; Vahl N; Hansen TB; Thuesen L; Hagen C; Christiansen JS
Clin Endocrinol (Oxf); 1996 Dec; 45(6):681-8. PubMed ID: 9039333
[TBL] [Abstract][Full Text] [Related]
28. Sustained reduction in circulating cholesterol in adult hypopituitary patients given low dose titrated growth hormone replacement therapy: a two year study.
Florakis D; Hung V; Kaltsas G; Coyte D; Jenkins PJ; Chew SL; Grossman AB; Besser GM; Monson JP
Clin Endocrinol (Oxf); 2000 Oct; 53(4):453-9. PubMed ID: 11012570
[TBL] [Abstract][Full Text] [Related]
29. Comparative results of a 4-year study on cardiovascular parameters, lipid metabolism, body composition and bone mass between untreated and treated adult growth hormone deficient patients.
Fideleff HL; Boquete HR; Stalldecker G; Giaccio AV; Sobrado PG
Growth Horm IGF Res; 2008 Aug; 18(4):318-24. PubMed ID: 18289903
[TBL] [Abstract][Full Text] [Related]
30. One year of GH replacement therapy with a fixed low-dose regimen improves body composition, bone mineral density and lipid profile of GH-deficient adults.
Boguszewski CL; Meister LH; Zaninelli DC; Radominski RB
Eur J Endocrinol; 2005 Jan; 152(1):67-75. PubMed ID: 15762189
[TBL] [Abstract][Full Text] [Related]
31. Improvement in insulin sensitivity without concomitant changes in body composition and cardiovascular risk markers following fixed administration of a very low growth hormone (GH) dose in adults with severe GH deficiency.
Yuen KC; Frystyk J; White DK; Twickler TB; Koppeschaar HP; Harris PE; Fryklund L; Murgatroyd PR; Dunger DB
Clin Endocrinol (Oxf); 2005 Oct; 63(4):428-36. PubMed ID: 16181235
[TBL] [Abstract][Full Text] [Related]
32. Optimizing growth hormone replacement therapy by dose titration in hypopituitary adults.
Drake WM; Coyte D; Camacho-Hübner C; Jivanji NM; Kaltsas G; Wood DF; Trainer PJ; Grossman AB; Besser GM; Monson JP
J Clin Endocrinol Metab; 1998 Nov; 83(11):3913-9. PubMed ID: 9814468
[TBL] [Abstract][Full Text] [Related]
33. Assessment of quality of life on 4-year growth hormone therapy in Japanese patients with adult growth hormone deficiency: A post-marketing, multicenter, observational study.
Ishii H; Shimatsu A; Nishinaga H; Murai O; Chihara K
Growth Horm IGF Res; 2017 Oct; 36():36-43. PubMed ID: 28923784
[TBL] [Abstract][Full Text] [Related]
34. Circulating IGF-I levels in monitoring and predicting efficacy during long-term GH treatment of GH-deficient adults.
Ezzat S; Fear S; Gaillard RC; Gayle C; Marcovitz S; Mattioni T; Nussey S; Rees A; Svanberg E
Eur J Endocrinol; 2003 Dec; 149(6):499-509. PubMed ID: 14640990
[TBL] [Abstract][Full Text] [Related]
35. Effects of growth hormone replacement on physical performance and body composition in GH deficient adults.
Rodríguez-Arnao J; Jabbar A; Fulcher K; Besser GM; Ross RJ
Clin Endocrinol (Oxf); 1999 Jul; 51(1):53-60. PubMed ID: 10468965
[TBL] [Abstract][Full Text] [Related]
36. Effects of four years' treatment with biosynthetic human growth hormone (GH) on body composition in GH-deficient hypopituitary adults.
Al-Shoumer KA; Page B; Thomas E; Murphy M; Beshyah SA; Johnston DG
Eur J Endocrinol; 1996 Nov; 135(5):559-67. PubMed ID: 8980158
[TBL] [Abstract][Full Text] [Related]
37. Growth hormone deficiency and replacement in elderly hypopituitary adults. KIMS Study Group and the KIMS International Board. Pharmacia and Upjohn International Metabolic Database.
Monson JP; Abs R; Bengtsson BA; Bennmarker H; Feldt-Rasmussen U; Hernberg-Stâhl E; Thorén M; Westberg B; Wilton P; Wüster C
Clin Endocrinol (Oxf); 2000 Sep; 53(3):281-9. PubMed ID: 10971444
[TBL] [Abstract][Full Text] [Related]
38. Growth hormone (GH) replacement therapy in adult-onset gh deficiency: effects on body composition in men and women in a double-blind, randomized, placebo-controlled trial.
Hoffman AR; Kuntze JE; Baptista J; Baum HB; Baumann GP; Biller BM; Clark RV; Cook D; Inzucchi SE; Kleinberg D; Klibanski A; Phillips LS; Ridgway EC; Robbins RJ; Schlechte J; Sharma M; Thorner MO; Vance ML
J Clin Endocrinol Metab; 2004 May; 89(5):2048-56. PubMed ID: 15126520
[TBL] [Abstract][Full Text] [Related]
39. Circulating Irisin Levels in Children With GH Deficiency Before and After 1 Year of GH Treatment.
Ciresi A; Pizzolanti G; Guarnotta V; Giordano C
J Clin Endocrinol Metab; 2019 Mar; 104(3):801-808. PubMed ID: 30418584
[TBL] [Abstract][Full Text] [Related]
40. Growth hormone replacement therapy in the elderly with hypothalamic-pituitary disease: a dose-finding study.
Toogood AA; Shalet SM
J Clin Endocrinol Metab; 1999 Jan; 84(1):131-6. PubMed ID: 9920073
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
